[1]
“Common Challenges to the Development of Novel Antivirals to Tackle Re-emerging Infections of Pandemic Potential”, acbr, vol. 10, no. 2, pp. 99–107, Mar. 2026, Accessed: Oct. 23, 2026. Available: https://www.fortunejournals.org/ojs/index.php/acbr/article/view/15170